MyZA

News, Directory, Events and Other Stuff

You are here: Home / Archives for Vaccines

Vaccines

Scaling up response to curb growing mpox outbreak in African region

Location: News

WHO Regional Office for Africa
Download logo

As the mpox outbreak that has affected the Democratic Republic of the Congo and spread to neighbouring countries continues to grow, World Health Organization (WHO) is intensifying support to countries to scale up measures to curb the virus and save lives.

On the advice of independent experts of the International Health Regulations Emergency Committee, WHO Director-General has determined that the upsurge of mpox constitutes a public health emergency of international concern (PHEIC). The emergence of a new strain of the mpox virus in the Democratic Republic of the Congo and its rapid spread, including to neighbouring countries, is one of the main reasons for the declaration of the PHEIC, the second such determination in two years relating to the disease.

So far this year, more than 2100 laboratory-confirmed cases and 13 deaths have been reported from 12 countries (Burundi, Cameroon, Central African Republic, Congo, Cote d'Ivoire, the Democratic Republic of the Congo, Kenya, Liberia, Nigeria, Rwanda, South Africa and Uganda) compared with 1145 confirmed cases and seven deaths in the whole of 2023 reported from 11 countries.

“We are hard at work on the frontlines of the response, collaborating closely with governments and communities to strengthen mpox control measures and are ramping up efforts to curb the widening trend of the virus through coordinated action with partners and national authorities,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

WHO is stepping up support to the affected countries by deploying additional experts, including epidemiologists and anthropologists, and providing initial funding to accelerate outbreak response measures. Efforts are also underway to enhance cross-border collaboration for case investigation, contact tracing and community engagement to ensure compliance with preventive measures.

The Organization also supporting national regulatory authorities to speed up regulatory approvals, as well as providing guidance to national immunization technical advisory groups to ensure readiness for vaccine rollout.  WHO has triggered the process for Emergency Use Listing for mpox vaccines, which will accelerate vaccine access for lower-income countries which have not yet issued their own national regulatory approval. Emergency Use Listing also enables partners including Gavi, the Vaccine Alliance, and UNICEF to procure vaccines for distribution.

Efforts are also being ramped up to strengthen national diagnostic capacities by providing testing kits and reagents and machines to decentralize testing. Genomic sequencing is also ongoing to determine the mpox clades.

To enhance preparedness in countries neighbouring the Democratic Republic of the Congo and those at risk, disease surveillance and training of frontline health workers is being stepped up as well as public awareness campaigns.

Caused by an Orthopoxvirus, mpox was first detected in humans in 1970, in the Democratic Republic of the Congo. The disease is considered endemic to countries in central and west Africa. Mpox is transmitted from animals to humans. It can also spread from humans to humans through contact with bodily fluids, lesions on the skin or on internal mucosal surfaces, such as in the mouth or throat, respiratory droplets and contaminated objects.

Distributed by APO Group on behalf of WHO Regional Office for Africa.

Read moreScaling up response to curb growing mpox outbreak in African region

WHO declares mpox outbreaks in Africa a global health emergency

Location: News

WHO declares mpox outbreaks in Africa a global health emergency

The ongoing outbreak of Mpox has been officially declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organisation (WHO).

The upsurge of Mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa has been determined by the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, to constitute a 
Public Health Emergency of International Concern (PHEIC) under the International Health Regulations (IHR).

Ghebreyesus’ declaration came on the advice of an IHR Emergency Committee of independent experts who met on Wednesday to review data presented by experts from the WHO and affected countries. 

A PHEIC is the highest alert level under international health law.

“The emergence of a new clade of Mpox, its rapid spread in eastern DRC, and the reporting of cases in several neighbouring countries are very worrying. On top of outbreaks of other Mpox clades in DRC and other countries in Africa, it’s clear that a coordinated international response is needed to stop these outbreaks and save lives,” Ghebreyesus said. 

WHO Regional Director for Africa, Dr Matshidiso Moeti, said significant efforts are already underway in close collaboration with communities and governments, with country teams working on the frontlines to help reinforce measures to curb Mpox. 

“With the growing spread of the virus, we’re scaling up further through coordinated international action to support countries bring the outbreaks to an end,” she said. 

Committee Chair, Professor Dimie Ogoina, indicated that the current upsurge of Mpox in parts of Africa, along with the spread of a new sexually transmissible strain of the Mpox virus, is an emergency, not only for Africa but for the entire globe. 

“Mpox, originating in Africa, was neglected there, and later caused a global outbreak in 2022. It is time to act decisively to prevent history from repeating itself.”

According to the WHO, the multi-country outbreak of Mpox was declared a PHEIC in 2022 after it spread rapidly via sexual contact across a range of countries where the virus had not been seen before. 

That PHEIC was declared over in May 2023 after there had been a sustained decline in global cases.
Meanwhile, Mpox has been reported in the DRC for more than a decade, and the number of cases reported each year has increased steadily over that period. 

Last year, the WHO said reported cases increased significantly, and already the number of cases reported so far this year has exceeded last year’s total, with more than 15 600 cases and 537 deaths.

“The emergence last year and rapid spread of a new virus strain in DRC, clade 1b, which appears to be spreading mainly through sexual networks, and its detection in countries neighbouring the DRC is especially concerning, and one of the main reasons for the declaration of the PHEIC,” the WHO said. 

In South Africa, the total number of cases stands at 24, of which 12 were reported in Gauteng, 11 in KwaZulu-Natal and one in the Western Cape and three deaths. 

Vaccine donation

The WHO announced it was working with countries and vaccine manufacturers on potential vaccine donations and coordinating with partners through the interim Medical Countermeasures Network to facilitate equitable access to vaccines, therapeutics, diagnostics and other tools.

The WHO said it anticipates an immediate funding requirement of an initial US$ 15 million to support surveillance, preparedness and response activities. 

To allow for an immediate scale-up, the WHO said it has released US$ 1.45 million from the WHO Contingency Fund for Emergencies and may need to release more in the coming days. 

“The organisation appeals to donors to fund the full extent of needs of the Mpox response.”

READ | Everything you need to know about Mpox disease – SAnews.gov.za

 

Gabisile
Thu, 08/15/2024 - 09:57

133 views
Read moreWHO declares mpox outbreaks in Africa a global health emergency

Africa Centres for Disease Control and Prevention (Africa CDC) Declares Mpox A Public Health Emergency of Continental Security, Mobilizing Resources Across the Continent

Location: News

Africa Centres for Disease Control and Prevention (Africa CDC)
Download logo

The Africa Centres for Disease Control and Prevention (Africa CDC) has officially declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.

This declaration, under Article 3, Paragraph F of the Africa CDC Statutes, empowers the organization to lead and coordinate responses to significant health emergencies. The statute mandates Africa CDC to “coordinate and support Member States in health emergency responses, particularly those declared PHECS or Public Health Emergency of International Concern (PHEIC), as well as health promotion and disease prevention through health systems strengthening, addressing communicable and non-communicable diseases, environmental health, and Neglected Tropical Diseases.”

The declaration will enable the mobilization of resources across affected countries, unlocking essential funding, strengthening Risk Communication and Community Engagement (RCCE), boosting surveillance and laboratory testing efforts, and enhancing human resource capacities to respond effectively to Mpox through a One Health approach.

Africa CDC Director General Dr. Jean Kaseya emphasized the urgency of swift and decisive action: “Today, we declare this PHECS to mobilize our institutions, our collective will, and our resources to act—swiftly and decisively. This empowers us to forge new partnerships, strengthen our health systems, educate our communities, and deliver life-saving interventions where they are needed most. There is no need for travel restrictions at this time.”

At least 13 African countries, including previously unaffected nations like Burundi, Kenya, Rwanda, and Uganda, have reported Mpox outbreaks. So far in 2024, these countries have confirmed 2,863 cases and 517 deaths, primarily in the Democratic Republic of the Congo (DRC). Suspected cases across the continent have surged past 17,000, a significant increase from 7,146 cases in 2022 and 14,957 cases in 2023. This is just the tip of the iceberg when we consider the many weaknesses in surveillance, laboratory testing and contact tracing.

Dr. Kaseya underscored the gravity of the situation stating “This is not just another challenge; it's a crisis that demands our collective action. Article 3, Paragraph F of the Africa CDC Statutes mandates us to lead and coordinate the response when there is a declaration of a public health emergency of international concern.”

From May 2022 to July 2023, Mpox was declared a Public Health Emergency of International Concern (PHEIC) by the WHO. However, Africa did not receive the support it urgently needed during this period. As global cases began to decline, the escalating numbers in Africa were largely ignored. Dr. Kaseya emphasized the need for a change in approach: “We urge our international partners to seize this moment to act differently and collaborate closely with Africa CDC to provide the necessary support to our Member States.”

He continued, appealing to global partners: “We call on you to stand with us in this critical hour. Africa has long been on the frontlines in the fight against infectious diseases, often with limited resources. The battle against Mpox demands a global response. We need your support, expertise, and solidarity. The world cannot afford to turn a blind eye to this crisis.”

He explained that the emergency declaration follows wide consultations, including a unanimous decision by the Africa CDC Emergency Consultative Group (ECG), chaired by Professor Salim Abdool Karim, head of CAPRISA, an AIDS research program based in Durban, South Africa.

Prof. Karim highlighted that limited surveillance and evidence suggest the situation could be more severe than currently understood. “The number of cases has significantly increased compared to 2022 when WHO declared Mpox a public health emergency. It's clear that we're facing a different scenario with far more cases, resulting in a higher burden of illness,” he said. He also raised concerns about the rising fatalities, particularly the potential link between HIV and Mpox. “Our concern is that we may be seeing more fatalities in Africa due to the association with HIV,” he noted.

Cross-border transmission to previously unaffected countries was also a concern, prompting the ECG to urge the strategic distribution of the limited vaccines available. The lack of diagnostic capabilities was identified as a critical issue requiring urgent attention, and the ECG encouraged the development of response plans, promising to provide input and support.

To address the Mpox outbreak in Africa, Africa CDC has set up a 25-member Incident Management Team based at the epicenter of the Mpox epidemic with mandate to support affected and at-risk countries. Africa CDC has also signed a partnership agreement with the European Commission's Health Emergency Preparedness and Response Authority (HERA) and Bavarian Nordic to provide over 215,000 doses of the MVA-BN® vaccine—the only FDA and EMA-approved Mpox vaccine. Africa CDC will oversee the equitable distribution of these vaccines, prioritizing local needs across the affected Member States.

MPOX SYMPTOMS, PREVENTION, AND TREATMENT

Mpox is a viral illness caused by the monkeypox virus, with two distinct clades: Clade I and Clade II. Common symptoms include a skin rash or mucosal lesions lasting 2–4 weeks, fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes. The virus can be transmitted to humans through physical contact with an infectious person, contaminated materials, or infected animals.

Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).

Read moreAfrica Centres for Disease Control and Prevention (Africa CDC) Declares Mpox A Public Health Emergency of Continental Security, Mobilizing Resources Across the Continent

President Ramaphosa to Officiate Signing of the Second Presidential Health Compact

Location: News

The Presidency of the Republic of South Africa
Download logo

President Cyril Ramaphosa will on Thursday, 15 August 2024, preside over the signing of the second Presidential Health Compact at the Union Buildings in Pretoria.

The second compact follows the 2023 Presidential Health Summit which built on the inaugural summit of 2018 and brought together government, business, labour, civil society, health professionals, unions, service users, statutory councils, academia, and researchers to develop sustainable and inclusive solutions to challenges in the national health system.

The stakeholders involved in the Presidential Health Compact are integral to supporting the Department of Health in improving the health system.

It initially consisted of nine pillars with a 10th pillar added during last year's summit. 

These include development of human resources; improving access to medicine, vaccines and health products; upgrading infrastructure; private sector engagement; quality healthcare; public sector financial management improvements; governance and leadership; community engagements; information systems and pandemic preparedness.

The signing of the second Presidential Health Compact will take place as follows:
Date: Thursday, 15 August 2024 
Time: 14h30 (Media to arrive at 13h00) 
Venue: Union Buildings Courtyard, West Wing, Pretoria

Members of the media wishing to cover the event are asked to send their details to  Makungu Mbetse on makungu@presidency.gov.za and copy Patience Mtshali on patience@presidency.gov.za not later than today, Tuesday, 13 August 2024 at 17h00.

Distributed by APO Group on behalf of The Presidency of the Republic of South Africa.

Read morePresident Ramaphosa to Officiate Signing of the Second Presidential Health Compact

President Ramaphosa to officiate signing of the Presidential Health Compact

Location: News

President Ramaphosa to officiate signing of the Presidential Health Compact

President Cyril Ramaphosa will on Thursday, 15 August 2024, preside over the signing of the second Presidential Health Compact at the Union Buildings in Pretoria.

The second compact follows the 2023 Presidential Health Summit which built on the inaugural summit of 2018 and brought together several stakeholders. 

These include government, business, labour, civil society, health professionals, unions, service users, statutory councils, academia, and researchers to develop sustainable and inclusive solutions to challenges in the national health system. 

According to the statement, the stakeholders involved in the Presidential Health Compact are integral to supporting the Department of Health in improving the health system.

The Presidential Health Compact initially consisted of nine pillars with the tenth pillar added during last year’s summit. 

These include the development of human resources, improving access to medicine, vaccines and health products, upgrading infrastructure, private sector engagement, quality healthcare, public sector financial management improvements, governance and leadership, community engagements, information systems and pandemic preparedness. – SAnews.gov.za
 

Gabisile
Tue, 08/13/2024 - 10:29

89 views
Read morePresident Ramaphosa to officiate signing of the Presidential Health Compact

African region faces an unprecedent surge in mpox cases

Location: News

WHO Regional Office for Africa
Download logo

The African region is experiencing an unprecedented increase in mpox cases since the start of 2024, with more countries previously unaffected by the disease reporting cases in an expanding spread of the virus.

World Health Organization (WHO) has elevated the mpox outbreak response to the highest-level requiring organization-wide mobilization and scale-up. In addition, WHO Director-General Dr Tedros Adhanom Ghebreyesus has called for an emergency committee of experts meeting to determine whether the outbreak constitutes a Public Health Emergency of International Concern.

Fifteen African countries are currently reporting mpox outbreak, with a total of 2030 confirmed cases and 13 deaths so far this year compared with 1145 cases and seven deaths in the whole of 2023. Four countries – Burundi, Kenya, Rwanda and Uganda – previously unaffected by mpox have reported cases since mid-July 2024.

In the Democratic Republic of the Congo, which accounts for more than 90% of the reported cases, a new variant that emerged in September 2023 is circulating in its eastern region. Neighbouring Rwanda and Uganda have reported cases of the new variant. Kenya has also confirmed cases of the new variant. Analysis are ongoing in Burundi to determine whether the reported cases are due to the new variant.

“The priority is to rapidly interrupt the transmission of the virus. We're collaborating with partners in support of countries to reinforce outbreak control measures and ensure that communities are central to ongoing efforts to effectively end these outbreaks,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

The pattern of transmission varies across the region, with the spread of new variant (known as clade 1b) in eastern Democratic Republic of the Congo linked to transmission through sexual contact and high population movement, while in South Africa most of the cases are among people identifying as men having sex with men. Transmission in West and Central Africa is associated with the 2022 global outbreak. However, further analysis is required to better understand the patterns of transmission to refine the response to the outbreak.

WHO is working at the global, regional and national levels as well as with partners, including the Africa Centres for Disease Control and Prevention and others to ensure effective response to the outbreak.  

In the African region, WHO is working through country teams and experts deployed on the ground to support national authorities strengthen key response areas, including disease surveillance, diagnosis testing and clinical care, infection prevention and control. WHO is working with the health authorities to access therapeutics, decentralize laboratory services for enhanced diagnostic capacities, and ramp up efforts to raise awareness about the risk of the disease among communities.

Field investigation and active case finding are also being reinforced in the affected and at-risk countries. The Organization is coordinating closely to enhance contact tracing, leveraging experience from prior outbreaks to ensure interventions best support and elevate the needs of key populations. WHO is also mobilizing financial support to help countries effectively respond to the outbreak.

WHO is advancing the process for Emergency Use Listing Procedure, an approach to assess and list unlicensed vaccines, therapeutics and diagnostics to expediting their availability for use during public health emergencies. The Organization is already working closely with countries to develop their vaccination strategies and plans, to roll out the vaccines as soon as they are available. Vaccines are one among many public health tools that are used to control mpox.

Mpox is transmitted from animals to humans, with cases often found close to tropical rainforests where there are animals that carry the virus. The disease can also spread from humans to humans through contact with bodily fluids, lesions on the skin or on internal mucosal surfaces, such as in the mouth or throat, respiratory droplets and contaminated objects.

Treatment of mpox patients is supportive dependent on the symptoms. Various therapeutics that may be effective against mpox are being developed and tested.  Prevention and control of rely on raising awareness in communities and educating health workers to prevent infection and stop transmission.

Distributed by APO Group on behalf of WHO Regional Office for Africa.

Read moreAfrican region faces an unprecedent surge in mpox cases

Governments urged to prioritise testing, treatment and vaccinating against hepatitis

Location: News

Governments urged to prioritise testing, treatment and vaccinating against hepatitis

A liver performs over 500 vital functions every single day to keep us alive, that is the reason that the World Health Organisation (WHO) believes testing, treating and preventing viral hepatitis is so important.

On Sunday, the globe commemorated World Hepatitis Day and the WHO called on all governments to prioritise testing, treatment and vaccination to realise a hepatitis-free world by 2030.

The Department of Health said viral hepatitis is a preventable and manageable disease, which remains a silent and neglected cause of morbidity and mortality worldwide. 

Hepatitis is an inflammation of the liver often caused by a virus. Viral hepatitis means there is a specific virus causing your liver to swell or become larger than normal.

World Hepatitis Day is observed each year on 28 July to educate the public about the disease and encourage people, health professionals, communities and governments to drive awareness and action to eliminate viral hepatitis.

“Viral hepatitis is responsible for an enormous health burden, mostly due to chronic hepatitis B and C infection,” the department explained. 

According to the 2024 WHO Global Hepatitis Report, in 2022, an estimated 304 million people were living with hepatitis B and hepatitis C globally. 

The department said viral hepatitis is the second leading infectious cause of death globally, with about 1.3 million deaths recorded annually around the world, including over 2 000 deaths recorded in South Africa. 

This burden is further compounded by the lack of screening, access to care and treatment, inadequate disease surveillance, and human and financial resources. 

Meanwhile, the department stated that people living with underlying conditions such as HIV are at a higher risk due to coinfection, which further exacerbates the burden of liver disease. 

South Africa is a signatory to the WHO’s global hepatitis strategy endorsed by other Member States, which aims to reduce new hepatitis infections by 90% and deaths by 65% between 2016 and 2030. 

The prevention of this infectious disease includes both pharmaceutical and non-pharmaceutical interventions such as vaccines, practising safer sex, good hygiene, avoid sharing needles, toothbrushes and razors. 

The department is also advising people to avoid drinking water from known potentially unsafe sources and cooking food well to help prevent the spread of the disease. 

While viral hepatitis is typically asymptomatic, the department said some signs may include fever, malaise, loss of appetite, diarrhoea, nausea, abdominal discomfort, dark-coloured urine and jaundice.

“In some cases, the virus can also cause a chronic liver infection or liver cancer, putting patients at a higher risk of death, unless they get treatment.”

The department has since developed National Guidelines for the Management of Viral Hepatitis as part of efforts to reduce morbidity and mortality in the country. 

People, especially those experiencing any of the hepatitis symptoms, are urged to go for screening and testing for early diagnosis and treatment depending on the type of hepatitis. 

In addition, those at higher risk of serious health complications if they contract hepatitis B and/or C need the vaccine, including all newborns and previously unvaccinated children and adolescents, people with more than one sex partner, key populations, and those infected with HIV and/or other sexually transmitted diseases. – SAnews.gov.za

 

Gabisile
Mon, 07/29/2024 - 10:11

357 views
Read moreGovernments urged to prioritise testing, treatment and vaccinating against hepatitis

World Bank Group Executive Directors note progress and re-affirm support to South Africa and Namibia

Location: News

The World Bank Group
Download logo

A delegation of the World Bank Group's (WBG) Board of Executive Directors (EDs) noted South Africa's and Namibia's progress in achieving their development goals and re-affirmed World Bank Group's commitment to providing support. The 11 EDs and Alternate EDs were hosted by the World Bank and International Finance Corporation (IFC) country offices during their recent visit on July 7-13.

The visit provided a platform to assess progress with projects and engage on the evolution of the World Bank Group's relationship with the countries, from a knowledge-focused to a broader knowledge and financing partnership. EDs met government and business leaders, local stakeholders, and project beneficiaries, and experienced first-hand how the countries manage development priorities and challenges. South Africa and Namibia have common challenges, including poverty, unemployment, and inequality. Throughout the visit, the delegation discussed the ongoing and future support from the World Bank Group to boost inclusive economic growth and job creation.

In South Africa, over the past three years the country has shifted from being a non-borrowing client to borrowing over $1 billion per year from the World Bank. South Africa also constitutes the largest IFC portfolio in Africa and the Multilateral Investment Guarantee Agency's (MIGA) second largest on the continent.

In Namibia, the World Bank Group is preparing a new Country Partnership Framework (CPF) with the government that will strategically guide its support as the engagement continues to grow. The World Bank recently approved a $138.5 million renewable energy and transmission loan to NamPower, after 15 years without borrowing.

Key highlights of the visit included:

  • In South Africa, the delegation met with the Minister of Finance Honorable Enoch Godongwana, and the Minister of Electricity and Energy Honorable Kgosientsho Ramokgopa. EDs visited two IFC clients and two World Bank projects which showcased support for key government priorities and demonstrated how these projects link to global issues and corporate initiatives such as the just energy transition, health, urban development, and subnational government engagement. The delegation toured and engaged with stakeholders at the Komati power station – the site of the Eskom Just Energy Transition Project; the Addo Elephant Park that houses the innovative Wildlife Conservation Bond; and the IFC-supported Trust for Urban Housing Finance and BioVac Institute that manufactures vaccines locally.
  • In Namibia, the delegation met with Minister of Finance and Public Enterprises Honorable Ipumbu Shiimi and key stakeholders, including development partners and the private sector.  The delegation visited informal settlements near Windhoek to gain insights on housing related issues, a sector where IFC is investing and which the government has identified as a priority for World Bank Group engagement.

Matteo Bugamelli, the World Bank's Executive Director who represents the constituency of countries including Albania, Greece, Italy, Malta, Portugal, San Marino, and Timor-Leste, expressed optimism about the countries' progress. He emphasized the World Bank Group's commitment to helping South Africa and Namibia address unemployment and inequality challenges. He particularly welcomed the increased financing to support the implementation of much needed reforms.

About the World Bank Group's Board of Directors: The Board of Executive Directors is responsible for the conduct of the general operations of the Bank, making decisions on loans, credits, grants, policies, and financial matters. The Board consists of 25 members who represent the 189 member countries, providing guidance for the institution's development activities.

Visiting Board Officials: The delegation included Mr. Abdulaziz E A Almulla (Executive Director for Bahrain, Arab Republic of Egypt, Jordan, Iraq, Kuwait, Lebanon, Maldives, Oman, Qatar, United Arab Emirates, West Bank and Gaza, and Republic of Yemen); Mr. Matteo Bugamelli (Executive Director for Albania, Greece, Italy, Malta, Portugal, San Marino, and Timor-Leste); Ms. Ayanda Dlodlo (Executive Director Angola, Nigeria, South Africa); Mr. Floribert Ngaruko (Executive Director for Botswana, Burundi, Eritrea, Eswatini, Ethiopia, The Gambia, Kenya, Lesotho, Liberia, Malawi, Mozambique, Namibia, Rwanda, Seychelles, Sierra Leone, Somalia, South Sudan, Sudan, Tanzania, Uganda, Zambia and Zimbabwe); Ms. Katharine Rechico (Executive Director for Antigua & Barbuda, The Bahamas, Barbados, Belize, Canada, Dominica, Grenada, Guyana, Ireland, Jamaica, St. Lucia, St. Kitts & Nevis and St. Vincent & the Grenadines); and Mr. Tauqir Shah (Executive Director for Afghanistan, Algeria, Ghana, Islamic Republic of Iran, Morocco, Pakistan, and Tunisia.

Visiting Alternate Executive Directors:  Mr. Louis Albisson (Alternate Executive Director for France); Mr. Felice Gorordo (Alternate Executive Director for the United States), Mr. Koji Uemura (Alternate Executive Director for Japan); Ms. Kerstin Sumana Wijeyewardene (Alternate Executive Director for Asia and the Pacific Constituency) and Mr. Weifeng Yang (Alternate Executive Director for China).

Included in the delegation was Ms. Mercy Tembon, World Bank Vice President and Corporate Secretary.

Distributed by APO Group on behalf of The World Bank Group.

Read moreWorld Bank Group Executive Directors note progress and re-affirm support to South Africa and Namibia

SA to work with Palestine in research, technology and innovation programme

Location: News

SA to work with Palestine in research, technology and innovation programme

Department of Science and Innovation (DSI) Minister, Professor Blade Nzimande,  has announced a new programme to foster cooperation in science, technology and innovation (STI) between South Africa and war-torn Palestine. 

“The programme will also have a special focus support for safeguarding, rebuilding, and developing Palestine’s research and innovation capacities and infrastructure,” Nzimande explained on Tuesday.

According to the Minister, the decision was made following a series of collaborations between the two nations. 

These include a joint research project, seed funding for developing South African–Palestinian knowledge networks, the hosting of Palestinian scholars and students in South Africa in exchange programmes and sharing South African policy experience regarding science policy and system development.

The Minister, delivering his 2024/25 Budget Vote, stated that the programme aligns with the department’s strategic objective of using science diplomacy to foster human solidarity, and social justice, and support the country’s foreign policy.

“This new programme will be implemented by our entity the NRF [National Research Foundation] and will be funded from the department’s existing budget for international cooperation,” he told Members of Parliament (MPs). 

Vaccines
 

For the 2024/25 financial year, the department experienced a budget cut, which was adjusted to R10 562 billion from R10 874 billion in 2023/24. 

“I am honoured to be delivering the first Budget Vote of the Department of Science and Innovation, under the seventh administration, in the same year we celebrate 30 years of democracy. 

“In these 30 years, our country has made tremendous strides in science, technology, and innovation,” he added. 

He highlighted some of the achievements under the previous administration, which he believes have laid a foundation for deepening work in the new government.  

This includes a new Vaccine Manufacturing Strategy (VIMS) to promote domestic design, development and production of vaccines.

Through VIMS, the department targeted vaccine development to fight the Rift Valley fever (RVF), human papillomavirus (HPV), respiratory syncytial virus (RSV) and the hepatitis B virus. 

Working with the World Health Organisation (WHO), government also set up capacity for the local development of mRNA vaccines in response to future Coronavirus threats. 

Hydrogen economy 

Nzimande also touched on the hydrogen economy, which was specifically referenced by President Cyril Ramaphosa in his Opening of Parliament Address (OPA) last Thursday. 

“The DSI is leading major innovations to promote the transition to green hydrogen as an alternative source of energy to fuel our economy and to facilitate a net-zero energy future,” he explained.  

In 2023/24, they also provided R53 million as an initial investment to support women-led small, medium, and micro-enterprises (SMMEs) in the hydrogen economy. 

Achievements

A national solar research facility was also established by the government to enable localisation and technology transfer in support of the Cannabis Industrialisation Masterplan and the Renewable Energy Masterplan. 

“Arising from this, it is pleasing to report that the CSIR [Council for Scientific and Industrial Research] graduated 23 SMMEs with two commercial value-added products each.” 

The Minister also highlighted the role of the department in leading scientific and technological advancements in the field of astronomy, particularly in the construction of the Square Kilometre Array (SKA) project, which is poised to become the world’s biggest-ever radio telescope array. 

In the area of agro-processing and farmer development in the 2023/24 period, the department provided 1 480 black emerging farmers with technology development support. 
 

New growth industries

Building on the successes of the sixth administration, the Minister said they remain committed to ensuring the sustainability of existing businesses in the agricultural, manufacturing and mining sectors and supporting the development of new growth industries. 

“STI is also about transforming the socio-economic conditions of working-class communities in townships and rural areas.”

He also touched on the Mandela Mining Precinct, a public-private partnership between the DSI and the Minerals Council of South Africa aimed at revitalising mining research, development and innovation to ensure the sustainability of the industry.

As part of building a capable State, he said his department has begun establishing an Earth Observation Data Centre to provide decision support tools for government in fire and flood mapping, food security monitoring, human settlements mapping, forest mapping, disaster management, climate change and water resources management. 

In addition, he told Parliament that government was looking at ways of raising gross expenditure on research and development (GERD) equal to 1.5% of the gross domestic product (GDP) by 2030/31. 

“Our challenges notwithstanding, we present this budget as our commitment to transform our National System of Innovation and using science, technology, and innovation to impact the lives of our people in a transformative way,” he added. – SAnews.gov.za

Gabisile
Tue, 07/23/2024 - 13:15

417 views
Read moreSA to work with Palestine in research, technology and innovation programme

Understanding Mammography: Essential Information on Mammograms

Location: MyPR

Introduction Mammograms are a critical tool in the early detection of breast cancer. This blog provides essential information on mammograms, their importance, and what to expect during the screening process. What is a Mammogram? A mammogram is an X-ray picture of the breast used to detect early signs of breast cancer. Regular mammograms are the …

Read moreUnderstanding Mammography: Essential Information on Mammograms

Click and Check: Discovery Vitality and RecoMed Simplify Flu Vaccinations and Vitality Health Checks

Location: MyPR

The online platform built by RecoMed for Discovery Vitality makes booking health checks and vaccines as simple as a few clicks. • Discovery Vitality members can book their flu vaccine at more than 1,000 locations • Users can find their nearest Discovery Vitality accredited centre and make an instant booking for either a Vitality Health …

Read moreClick and Check: Discovery Vitality and RecoMed Simplify Flu Vaccinations and Vitality Health Checks

Dalberg Implement: Integrating Strategy Design with Execution

Location: News
Dalberg Advisors

Dalberg (www.Dalberg.com) is a strategic advisory firm that combines the best of private sector strategy skills and rigorous analytical capabilities with deep knowledge and networks across emerging and frontier markets. All projects include an option to integrate strategy design with implementation. With staff on the ground in more than 50 countries, speaking over 90 languages, and understanding diverse sectoral priorities and nuances, Dalberg is able to bring a local team to execute solutions tailored for the local market—while simultaneously drawing on global topical expertise and insight. Dalberg also offers the advantage of continuity. “The trusting relationships we build during the strategy phase carry through the inevitable pitfalls of execution,” points out Shruti Goyal, an Associate Partner with Dalberg. “We maintain senior project leadership from strategy through to execution and learning. This provides smooth transitions between phases of the project. Our ability to support clients in shaping their strategy is enhanced by bringing in the learning from implementation, particularly in addressing shifting client priorities, external disruptions, and opportunities.”

Since 2020, Dalberg has collaborated with governments, philanthropies, multilaterals, NGOs, and corporates to seamlessly integrate strategy and execution support for over 55 projects—including, recently:

  • Establishing the Malaria Vaccine Technical Assistance Program—in collaboration with Gavi, the Vaccine Alliance—to tackle head-on the challenges in vaccine deployment in Sub-Saharan Africa
  • Designing, testing, and scaling financial and non-financial solutions tailored to the unique needs and aspirations of rural women in Kenya.
  • Designing India's first Skill Impact Bond (SIB)—an innovative approach to financing skilling and employment endeavors—and serving as performance manager to ensure the achievement of long-term career outcomes for young women.[SG1] [VK2] 

Dalberg's local presence also allows it to partner with grassroots organizations to drive implementation at the community level. “Our goal is systemic change,” says Goyal. “We hope to continue our deep partnerships from the start of the strategy journey through to execution to maximize the impact from our work.”

Below are two examples of how we have helped deliver complex assignments across multiple topics and geographies in Africa.

The Malaria Vaccine Technical Assistance Program – Lillian Kidane

Sub-Saharan Africa accounts for over 90% of malaria cases and related deaths globally and faces a host of challenges in vaccine deployment—from accessibility to integration with existing health systems. Earlier this year, Dalberg established the Malaria Vaccine Technical Assistance Program in collaboration with Gavi, the Vaccine Alliance. The initiative constitutes a comprehensive strategy to integrate the vaccine into national health systems, ensuring that the vaccine reaches the most vulnerable populations. Dalberg is working with multiple countries over the next three years to create tailored approaches to rolling out the new malaria vaccine. “We're already seeing results,” says Lillian Kidane, Partner and Dalberg's Regional Director for Africa. In Cameroon, for example, the successful launch of the malaria vaccine in 42 health districts has laid the groundwork for scaling up to the remaining 74 health districts. “The work also strengthens the case for promoting comprehensive healthcare delivery at the community level,” Kidane adds. Valuable insights from the program will facilitate the introduction of future vaccines, such as the human papillomavirus (HPV) vaccine.

Rural Women's Agricultural Aspirations – Naoko Koyama

Dalberg is working with the World Bank, Amtech, and CGAP to design, test, and scale financial and non-financial solutions to meet the unique needs and aspirations of rural women in Kenya. Through the program, Dalberg aims to increase rural women's use of financial and non-financial services, taking advantage of the national network of digitized and sustainable savings and credit cooperative organizations (SACCOs) as trusted community financial institutions, and strengthening access to markets through digitized farmer producer organizations (FPOs) and climate-smart agtechs and agribusinesses. The aim is to integrate services that include access to inputs, information, extension and capacity strengthening, and digital technology to enhance agricultural production. “Ultimately, we want to build more resilient agricultural livelihoods with increased access to financial services and markets, particularly for women,” says Naoko Koyama, a Dalberg Partner based in South Africa.

Looking forward

Dalberg sees a range of ways in which governments, philanthropies, multilaterals, NGOs, and private sector companies can accelerate their impact with implementation support, especially when they are taking on complex issues at the systems level. To learn more about our implementation work, please contact Shruti Goyal.

Contact: shruti.goyal@dalberg.com

ROUND 1

LinkedIn

Great strategies are only the first step. Turning them into real-world change requires specialized skills and resources.

This strategy-to-action gap is where we come in. Dalberg combines global best practices with deep local understanding, thanks to our team in over 50 countries. This allows us to tailor solutions that consider sectoral priorities and nuances.

[Link]

Learn more by contacting Shruti Goyal at shruti.goyal@dalberg.com.

#StrategyExecution #ImpactAtScale #LocalSolutions #SystemicChange #EmergingMarkets #GlobalExpertise #DevelopmentConsulting #DalbergImplement #SustainableDevelopment

Tweet

Turning strategies into real-world change requires specialized skills and resources. Dalberg bridges this gap with global best practices and deep local understanding. Boost your impact now: [Link] #StrategyExecution #ImpactAtScale #SystemicChange #DalbergImplement

Visual (Article grab/preview)

ROUND 2

LinkedIn

Great ideas are the fuel for progress. With Dalberg's implementation support, they can translate to great impact.

[Link]

Contact Shruti Goyal (shruti.goyal@dalberg.com) to learn more.

#StrategyExecution #ImpactAtScale #LocalSolutions #SystemicChange #EmergingMarkets #GlobalExpertise #DevelopmentConsulting #DalbergImplement #SustainableDevelopment

Visual (infographic: https://apo-opa.co/45NduFS)

Why Dalberg Implement?

Continuity: From strategy to execution to learning, led by the same leadership

Adaptability: To shifting priorities, external disruptions, and new opportunities

Credibility: Over 55 projects since 2020, across diverse sectors and geographies

Capacity: Teams in more than 50 countries, speaking over 90 languages

Tweet

Great ideas can translate to great impact with Dalberg's implementation support. Bring strategy to life with seamless execution: [Link] #LocalSolutions #SystemicChange #GlobalExpertise #DevelopmentConsulting #DalbergImplement

ROUND 3

LinkedIn

We believe our implementation support can significantly boost your impact on complex, systems-level issues.

Turn your ideas into lasting impact now: [Link]

 #StrategyExecution #ImpactAtScale #LocalSolutions #SystemicChange #EmergingMarkets #GlobalExpertise #DevelopmentConsulting #DalbergImplement #SustainableDevelopment

Quote card (https://apo-opa.co/3zpQH70)

“We maintain senior project leadership from strategy through to execution and learning. This provides smooth transitions between phases of the project. Our ability to support clients in shaping their strategy is enhanced by bringing in the learning from implementation, particularly in addressing shifting client priorities, external disruptions, and opportunities.”

Shruti Goyal, Associate Partner at Dalberg

Tweet

Dalberg's implementation support can significantly boost your impact on complex, systems-level issues. Turn your ideas into lasting impact now: [Link] #LocalSolutions #SystemicChange #GlobalExpertise #DevelopmentConsulting #DalbergImplement

 [SG1]Can we say ensure long term career outcomes for young women

 [VK2]Done.

Distributed by APO Group on behalf of Dalberg Advisors.

Media files
Dalberg Advisors
Download logo
Read moreDalberg Implement: Integrating Strategy Design with Execution

Everything you need to know about Mpox disease

Location: News

Everything you need to know about Mpox disease

As the number of Mpox cases continues to rise, the Department of Health has urged everyone with symptoms to immediately visit their nearest healthcare facilities for help. 

This week, this department announced that the country recorded three more infections and one death.

The latest figure pushes the total infections to 16 and three deaths since the first case was reported last month.

Of the 16 infections, eight are from KwaZulu-Natal, seven are from Gauteng, and one is from the Western Cape.

All individuals involved in the cases are male and aged between 23 and 43 years old.

What is Mpox?

Mpox, formerly known as monkeypox, is an infectious disease caused by the monkeypox virus. 

It can be transmitted to a person through contact with the virus from an animal, human, or materials contaminated with the virus.

Person-to-person transmission of the virus could be through close contact, which can be via prolonged face-to-face contact, kissing, sharing clothes or bedding with someone who is infected.

Entry of the virus is through broken skin, the respiratory tract, or mucous membranes (eyes, nose, or mouth).

According to the National Institute for Communicable Diseases (NICD), a person is contagious from the onset of the rash or lesions through the scab stage. However, once all scabs have fallen off, a person is no longer contagious.

Mpox is preventable and manageable, and treatment for both mild and severe cases is available. People at high risk include those living with chronic conditions such as HIV, tuberculosis (TB) and diabetes.

Anyone can contract the disease regardless of age, gender, sexual orientation and race.

Most people with Mpox will recover within two to four weeks.

Symptoms

Symptoms of the disease include fever and headache.

Other symptoms are:

  • muscle aches
  • backache
  • chills
  • exhaustion
  • swelling of lymph nodes as well as
  • skin lesions or rash that usually develops between one to three days and spread all over the body.

Diagnosis

According to the World Health Organisation (WHO), identifying Mpox can be difficult as other infections and conditions can look similar.

However, the WHO said it was crucial to differentiate Mpox from chickenpox, measles, bacterial skin infections, scabies, herpes, syphilis, other sexually transmissible infections, and medication-associated allergies.

Mpox’s rash begins as a flat sore, which develops into a blister, filled with liquid and may be itchy or painful.

In addition, the agency said that people with the disease may also have another sexually transmissible infection such as herpes, while a child with a suspected infection may also have chickenpox. It is for this reason that the WHO believes testing is key for people to get treatment as early as possible and prevent the further spread.

Self-care and prevention

The WHO is recommending steps to take to help the symptoms and prevent infecting others. These are:

  • Stay at home and in your room if possible.
  • Wash hands often with soap and water or hand sanitiser, especially before or after touching sores.
  • Wear a mask and cover lesions when around other people until your rash heals.
  • Keep skin dry and uncovered unless in a room with someone else.
  • Avoid touching items in shared spaces and disinfect shared spaces frequently.
  • Use saltwater rinses for sores in the mouth.
  • Take sitz baths or warm baths with baking soda or Epsom salts for body sores.
  • Take over-the-counter medications for pain like paracetamol or ibuprofen.

Department of Health's response

The department, working with provinces and other stakeholders in the sector, has embarked on health education with funeral parlours on how to handle the human remains of suspected and confirmed cases.

It has also urged travellers from Mpox endemic countries to seek healthcare if they are ill and to alert health officials about their travel for clinical guidance.

Citizens are also encouraged to support all those who are showing symptoms to present at their nearest healthcare facilities immediately for screening and diagnosis, instead of self-diagnosis and using over-the-counter medication.

Last week, the department said it has received a batch of Mpox-specific treatment, Tecovirimat – also known as TPOXX or ST-246, for the treatment of patients who experience severe health complications because of Mpox disease.

The department said it is in the process of securing more treatment, including vaccines.

However, according to the department, all mild cases will continue to be managed with supportive treatment used to manage complications like fever, pneumonia and skin infections. – SAnews.gov.za

Gabisile
Thu, 06/27/2024 - 12:03

90 views
Read moreEverything you need to know about Mpox disease

Mpox cases rise to 13

Location: News

Mpox cases rise to 13

South Africa has identified six additional laboratory-confirmed cases of Mpox, taking the total number of cases from seven to 13 since the first case was reported last month.

The Department of Health reported new infections in Gauteng and the Western Cape. The death toll is still at two. 

The first case of Monkeypox, now known as Mpox, was reported in South Africa on 9 May 2024, when a 35-year-old male living in Gauteng tested positive.

In the latest statement, the department said it has received a batch of Mpox-specific treatment, Tecovirimat - also known as TPOXX or ST-246, for treatment of patients who experience severe health complications because of Mpox disease. 

“The process to secure more treatment, including vaccines, is underway in case the need arises. However, all mild cases will continue to be managed with supportive treatment used to manage complications like fever, pneumonia and skin infections,” the department explained. 

READ | Mpox cases rise to seven in SA after new infection recorded in W Cape

Government is urging all people regardless of gender, age, or sexual orientation, with suspected Mpox symptoms or who had physical contact with known cases to present themselves at a healthcare facility because anyone can contract this preventable and treatable disease. 

The department stated that hand hygiene is one of the effective ways to protect people from getting sick and prevent transmission of diseases. 

“People are reminded to always wash hands with soap and water, or use an alcohol-based hand sanitiser, especially before eating or touching your face and after you use the bathroom.”

Some of the common symptoms of Mpox include a rash, which may last for two to four weeks, fever, headache, muscle aches, back pain, low energy and swollen glands. 

“The painful rash looks like blisters or sores, and can affect the face, palms of the hands, soles of the feet, groin, and so on.” – SAnews.gov.za

Gabisile
Fri, 06/21/2024 - 09:25

638 views
Read moreMpox cases rise to 13

SA records second death from Mpox, with six known positive cases

Location: News

SA records second death from Mpox, with six known positive cases

Health Minister Dr Joe Phaahla has announced a second death linked to Mpox, formerly known as monkeypox.

The announcement comes less than 24 hours after the government provided an update on its efforts to control the spread of the infectious disease.

According to the department, the deceased was a 38-year-old male patient, who was admitted at a local hospital in uMgungundlovu, KwaZulu-Natal.

The patient tested positive for Mpox on Wednesday after presenting with extensive lesions, lymphadenopathy, headache, fatigue, oral ulcers, muscle pain, and a sore throat.

“The patient has unfortunately demised in KwaZulu-Natal the same day his test results came back positive,” the statement read on Thursday. 

The deceased is said to have been living with HIV and listed his residential address as Brakpan in Gauteng. 

This brings the total number of positive cases in the country from five to six, and two deaths within five weeks. 

“The department is working closely with both Gauteng and KwaZulu-Natal Departments of Health to investigate the case. Further updates and reports will be provided once the investigation has been concluded.” 

Data shows that the sequencing results for the first three cases, sequence typed as clade ll b, the same as the sub-lineage responsible for the multi-country outbreak, which began in 2022 and has since spread to over 100 countries.

Phaahla emphasised the importance of personal hygiene, timely presentation at a health facility for early diagnosis, effective treatment in the case of suspected symptoms, and close physical contact with a known case.

“Mpox is a preventable and treatable disease if diagnosed early. People are urged to avoid physical contact with someone who has Mpox, practice hand hygiene and respiratory etiquette.” 

The department is also warning patients to avoid contact with immunocompromised people, children or pregnant women, who may be at higher risk of severe symptoms if exposed. 

Addressing the media on Wednesday, the Minister said there was currently no registered treatment for Mpox in South Africa. 

However, he said the World Health Organisation (WHO) recommends using Tecovirimat, also known as TPOXX, for treating severe cases, such as in individuals with a CD4 count of less than 350.

He announced that the department has obtained TPOXX via Section 21 South African Health Products Regulatory Authority (SAPHRA) approval on a compassionate use basis for known patients with severe disease.

The Minister said they are still looking at obtaining vaccines and considering various options, including who will be the priority target in terms of immunisation. 

Government is also looking at immunising sex workers, men who have sex with men (MSM), healthcare workers, and laboratory workers. 

The department, working together with partner organisations, has intensified both targeted and public awareness to empower citizens with crucial information related to Mpox. 

The Minister also emphasised the importance of managing stigma for key populations at risk, while there have been no recommendations for any travel restrictions.  

“I think one can safely say that, especially for adults, anybody who develops those kinds of eruptions on their skin, even if you may think it might be chickenpox, even young people, should seek medical attention,” he said. – SAnews.gov.za

 

Gabisile
Thu, 06/13/2024 - 10:18

856 views
Read moreSA records second death from Mpox, with six known positive cases

One Mpox patient passes away, while four are still in recovery

Location: News

One Mpox patient passes away, while four are still in recovery

Health Minister Dr Joe Phaahla has announced that one of the five Mpox patients in South Africa passed away on Monday at Tembisa Hospital in Gauteng.

This comes after two cases were confirmed in Gauteng and three in KwaZulu-Natal.

“In all cases, patients are males aged between 30 to 39 years without travel history to the countries currently experiencing an outbreak, which suggests there is local transmission of this infectious disease in the country,” the Minister said on Wednesday.

According to the Minister, the deceased was originally from KwaZulu-Natal but has not been at home since December last year. 

The Minister made these announcements during a media briefing on Wednesday centred on the management of the monkeypox outbreak in the country. 

Phaahla stated that all cases were classified as severe cases, as per the World Health Organisation (WHO) definition requiring hospitalisation.

The patients have comorbidities and have been identified as key populations, including men who have sex with men (MSM).

The Minister told the media that one of the patients has since been discharged, one is isolating at home, while two are still in hospital. 

Phaahla explained that the sequencing analysis of three of the cases revealed Mpox clade IIb, a variant dominant in the multi-country and post-outbreak, which began in 2022. 

The last time South Africa recorded positive cases of Mpox was in 2022, when five cases were confirmed in the Western Cape, KwaZulu-Natal, Limpopo and Gauteng, with no cases reported in 2023.

“So, the one in our country is consistent with the multi-country outbreaks in various parts of the world and different from the strain variant in the DRC,” he explained. 

Contact tracing 

The National Institute for Communicable Diseases (NICD), the Minister said, continues with epidemiological and surveillance activities to identify cases for investigation to estimate the magnitude of disease through systematic data collection and analysis. 

He told the media that 38 contacts were identified in KwaZulu-Natal, while one of the patients indicated to have had sexual contact with multiple partners, including both males and females.

Meanwhile, the Outbreak Response Team have embarked on contact tracing and case finding in the affected provinces.

“Encourage people who may know that in one way or another have been associated with someone with the disease or showing any symptoms of skin lesions or rashes to approach their nearest health facility.”

Vaccine

Currently, there is no registered treatment for Mpox in South Africa. 

However, the Minister said the WHO recommends using Tecovirimat, also known as TPOXX, for treating severe cases, such as in individuals with a CD4 count of less than 350.

He announced that the department has obtained TPOXX via Section 21 South African Health Products Regulatory Authority (SAPHRA) approval on a compassionate use basis for known patients with severe disease.

The Minister said they are still looking at obtaining vaccines and considering various options, including who will be the priority target in terms of immunisation. 

However, he believes that high-risk groups should be prioritised, including sex workers, MSM, healthcare workers, and laboratory workers. 

The department, working together with partner organisations, has intensified both targeted and public awareness to empower the citizens with crucial information related to Mpox. 

The Minister also emphasised the importance of managing stigma for key populations at risk, while there have been no recommendations for any travel restrictions.  

“I think one can safely say that, especially for adults, anybody who develops those kinds of eruptions on their skin, even if you may think it might be chickenpox, even young people, should seek medical attention.” 

He said government endeavours to prevent any further deaths. 

“We already have one fatality and he was quite sick, and were informed that even though the antiviral agent because of the severity of the sores, he could not swallow his treatment and died within a few days.” – SAnews.gov.za 
 

Gabisile
Wed, 06/12/2024 - 12:50

200 views
Read moreOne Mpox patient passes away, while four are still in recovery

President Ramaphosa, EU Council President hold bilateral call

Location: News

President Ramaphosa, EU Council President hold bilateral call

President Cyril Ramaphosa has held a bilateral telephone conversation with the President of the European Council, Charles Michel.

According to a statement by the Presidency, the conversation was a positive and constructive discussion on bilateral, regional, and global issues.

The statement said the two leaders also discussed the need for more engagement to address global peace and reaffirmed shared respect for international law.

“They both welcomed the recent bilateral South Africa-European Union Political and Security Dialogue Forum, and the Human Rights Dialogue held in Pretoria on 26 and 27 February 2024, and they agreed to continue stepping up cooperation to support stability and prosperity.

“In this regard, both Presidents discussed the importance of upholding the UN Charter and the principles of sovereignty and territorial integrity notably in Ukraine. Furthermore, both Presidents stressed the importance of addressing urgently the situation in the Middle East, notably reaching a ceasefire in Gaza, release of hostages as well as the provision of humanitarian assistance, recalling the orders of the International Court of Justice in this respect,” the Presidency said.

On matters relating to tensions in the East of the Democratic Republic of Congo, “both underlined the importance of a political solution” in that country and also called for an “immediate and durable ceasefire” in Sudan.

Globally, the two leaders agreed to closer working relations in the run up to and during South Africa’s upcoming Presidency of the G20 in 2025 “including on the protection and advancement of multilateral cooperation and the international rules-based order”.

The strategic partnership between South Africa and the European Union – which has brought economic and social dividends for both parties – also came under discussion.

“They welcomed recent engagements in Brussels and in Pretoria to deepen and expand the partnership to new areas of mutual interest, such as strategic value chains in the sectors of green hydrogen, critical minerals and vaccines, which will also support progress in regional integration and the implementation of the African Continental Free Trade Agreement.

“Against this framework of close and regular cooperation, both Presidents agreed to hold a bilateral Summit at earliest convenience,” the statement concluded. – SAnews.gov.za

 

NeoB
Tue, 05/21/2024 - 09:39

391 views
Read morePresident Ramaphosa, EU Council President hold bilateral call

Health dismisses reports of new COVID-19 variant

Location: News

Health dismisses reports of new COVID-19 variant

The National Department of Health says it has noted with concern old and fake news about the COVID-19 Omicron XBB variant circulating on social media.

These fake posts further advise people to wear face masks because of an allegedly “deadly and not easy-to-detect variant”.

“This is a misleading message which first resurfaced during the peak of the pandemic without a traceable source. 

“We urge members of the public to be vigilant and ignore this malicious social media content whose intent is to cause unnecessary panic and confusion, especially as the country is entering influenza season,” the department said in a statement on Tuesday. 

According to the department, COVID-19 remains circulating at relatively low levels around the country just like in other parts of the world. 

However, it said, there is no need for the public to panic because many people have developed some level of immunity from both the vaccines and infections.

“The current strain or variant in circulation is less severe and less transmissible.”

However, the department said that taking protective measures daily, including non-pharmaceutical interventions such as hand hygiene, will help to prevent the spread of other respiratory infections including influenza. 

“The department will keep the public abreast as and when there is a surge in cases of illness caused by any virus of concern or outbreak of any disease.” 

On Sunday, the department urged the public to take extra precautionary measures to protect themselves and their loved ones against respiratory infections, which are expected to increase over the winter season.

The National Institute for Communicable Diseases (NICD), which monitors the circulation of respiratory viruses throughout the country, has notified the department that it is currently the peak season of respiratory syncytial virus (RSV), which some can confuse for COVID-19 due to common symptoms. 

RSV causes illness mainly in young children but may also contribute to respiratory disease in older people.

The flu season is expected to start in the next few weeks and the department is advising those at high risk of contracting the virus to get the flu vaccine to prevent severe health complications. 

Groups at high risk include the elderly who are over 65 years old, those with underlying illnesses such as heart and lung disease, people living with HIV and tuberculosis, as well as pregnant people. – SAnews.gov.za

 

Gabisile
Tue, 04/30/2024 - 14:09

172 views
Read moreHealth dismisses reports of new COVID-19 variant

Mjwara’s departure bittersweet, says Minister Nzimande

Location: News

Mjwara's departure bittersweet, says Minister Nzimande

Minister of Higher Education, Science and Innovation, Professor Blade Nzimande, has described Dr Phil Mjwara’s farewell as bittersweet for both the department and the country’s science community.
 
The Department of Science and Technology (DSI) hosted a farewell for Mjwara, the longest-serving DG in the country, recently.
 
After serving for 18 years as DG, Mjwara has been praised for his significant contributions to the department and the country.
 
Mjwara, whose last day in office was on 28 March, was praised for his visionary leadership and dedication to a broader perspective.
 
“That’s one thing I enjoyed about you is you always contextualise and look at the bigger picture. But at the same time being specific about what needs to be done,” Nzimande told the attendees at the farewell. 
 
According to the Minister, Mjwara has played a crucial role in implementing key policies and institutional interventions with his strategic insights.
 
“I want to thank you for teaching me to be a science policy person. You know those who come from what is called a Marxist intellectual tradition. They usually are very arrogant about science. But thank you very much for teaching me many aspects of science that I didn’t know about,” he told Mjwara. 
 
Mjwara holds a BSc, MSc, and PhD from the University of the Witwatersrand. His academic career includes serving as a Professor of Science and Technology Policy at the University of Pretoria, and physics lectureships at the Universities of the Witwatersrand, South Africa, and Fort Hare.
 
Nzimande also saluted Mjwara for the outstanding work and the role he played in the management of the COVID-19 pandemic under the leadership of President Cyril Ramaphosa. 
 
He was also lauded for outstanding projects he was involved in such as hydrogen strategy, vaccine manufacturing innovations, indigenous knowledge systems projects and the National Policy Data Observatory. 
 
“Being in the department has been a learning curve for me and your presence has truly anchored me as a science policy person,” Nzimande added. 
 
The Minister also congratulated Mjwara because, for the first time in South Africa, the country has developed the capacity for the local production of vaccines. 
 
He gifted the retiree with a shield and a spear as a symbol for the fights he fought and conquered as a civil servant. 
 
“I want to say something to the staff of DSI that indeed we have very big shoes to fill.” 
 
Mjwara also took the podium to thank the guests for honouring him with their presence. He paid tribute to the Ministers and Special Advisors who have worked with him and his team over the years. 
 
“I appreciate that Ministers provided us with roles and gave us the space to do what needed to be done. The role was very clear.”
 
When he began his journey at DSI, he expressed his desire to create a machine that would make everyone proud.
 
“I am proud that we built this machinery. It will take somebody very skilful to [try to] dismantle this. I want to say here that I wish them all the best in trying to do it. Because it's been designed with all the checks and balances to make sure that those who have the ambitions to destroy this will not get into the entire DSI family I'm very proud of,” he said, an utterance which was met with cheers. 
 
He expressed his sincere gratitude to his staff from the Pretoria and Cape Town offices for all the support they provided to him and his family. 
 
Mjwara gave a special dedication to his assistants. “I am grateful that they all stayed with me because I can be very difficult.” 
 
He paid tribute to his wife, his three adult children, and his newly wedded daughter-in-law. “I know that I haven’t always been present and I apologise for not being there all the time but I hope now you know where I was,” he quipped. 
 
He said that he has not taken their support and sacrifice for granted.
  
During the event, Bongiwe, Mjwara’s daughter, shared some personal anecdotes and paid tribute to her father's character and achievements.
 
“With everything, he ran the household very systematically and had great organisational skills with everything. It is amazing to see everything that our father has done and how he has remained as a person. He's been to all these places, met all these people but continues to remain humble.” 
 
She described her dad as a humorous man with a charming smile.
 
“I just hope that in your projects going forward you’ll continue to use him but also let him enjoy life, enjoy his legacy and his family. You have set such a beautiful standard for excellence, respect, and humility and we are proud of you.” – SAnews.gov.za

 

Gabisile
Fri, 04/26/2024 - 13:37

34 views
Read moreMjwara’s departure bittersweet, says Minister Nzimande

Dr Phil Mjwara honoured for promoting science, technology and innovation in SA 

Location: News

Dr Phil Mjwara honoured for promoting science, technology and innovation in SA 

The Director-General of the Department of Science and Innovation (DSI), Dr Phil Mjwara, has been honoured for his visionary leadership in promoting science in South Africa and abroad. 

Mjwara received the Presidential Award during the annual South African Medical Research Council (SAMRC) Merit Awards in Cape Town on Thursday. 

With 18 years of service as Director-General, Mjwara was lauded for having significantly contributed to the South African National System of Innovation (NSI). 

Through these awards, the SAMRC said it acknowledges outstanding contributions to health research and recognises individuals who have demonstrated exceptional scientific acumen.

The awards recognise those who made innovative strides in addressing public health challenges, potentially influencing policy to enhance the well-being of all South Africans. 

Mjwara holds a BSc, MSc and PhD from the University of the Witwatersrand and his academic career includes serving as a Professor of Science and Technology Policy at the University of Pretoria, and physics lectureships at the universities of the Witwatersrand, South Africa, and Fort Hare. 

Speaking at the awards ceremony, SAMRC President Professor Glenda Gray said Mjwara had built a strong legacy in the country. 

“In the late 1990s, Dr Mjwara led South Africa’s first national Science and Technology Foresight Exercise, which laid the foundation for the NSI,” the statement read. 

Mjwara is also described as someone who is highly regarded in various global forums. 

The Director-General is a senior member of the United Nations Educational, Scientific and Cultural Organisation (UNESCO) International Basic Sciences Programme and the Square Kilometre Array Observatory Council. 

Mjwara has also been lauded for formulating the STI Decadal Plan, which has elevated STI to the presidential level, with the first Presidential Plenary held last year. 

This Decadal Plan, according to Gray, focuses on using STI to address societal challenges and highlights the importance of health research in the STI environment in South Africa. 

“Dr Mjwara has set the vision for all policy development in the science and technology sector in South Africa. He saw the need to create sustainable programmes, infrastructure and human capacity to ensure that South Africa achieves excellence in critical areas of science and technology," Gray said. 

The SAMRC also honoured the DSI’s Director for Health Innovation, Glaudina Loots, with a special award for her support and leadership in health research in the country. 

Loots is responsible for the implementation of the health components of the Bio-economy Strategy for South Africa. 

She has been instrumental in the creation of the Strategic Health Innovation Partnerships initiative at the SAMRC, which funds and manages innovation projects focused on the development of new drugs, treatments, vaccines, medical devices and prevention strategies. 

Gray explained that medical research remains fundamental for transformation, innovation and collaboration in advancing scientific discovery. 

“Celebrating medical research excellence not only honours the achievements of researchers but also inspires progress, fosters collaboration, and enhances the overall impact of scientific advancements on global health and well-being,” she said. – SAnews.gov.za
 

Gabisile
Fri, 03/08/2024 - 14:25

132 views
Read moreDr Phil Mjwara honoured for promoting science, technology and innovation in SA